Regional Analysis

Medical Affairs Outsourcing Market Regional Insights

To learn more about this report, Request sample copy

North America has been the dominant region in the global medical affairs outsourcing market with an estimated market share of 40.2 % in 2024. The strong presence of pharmaceutical and life sciences companies in the U.S. and Canada has boosted demand for outsourced medical support services. Leading pharmaceutical companies in the region are the early adopters of outsourcing non-core functions including medical affairs to focus on drug development. High costs of in-house medical teams and stringent regulatory compliance requirements have compelled more players to leverage experienced outsourcing partners. Key industry hubs such as Boston and New Jersey are major outsourcing destinations in North America, bolstered by the abundant talent pool available locally.

Asia Pacific has emerged as the fastest growing region for medical affairs outsourcing. Countries like India, China, South Korea and Singapore have witnessed massive expansion of their contract research and outsourcing industries. The availability of low-cost expertise, especially in functions like medical writing and scientific communication has attracted outsourcers to the Asia Pacific region. India has been proactively promoting medical research and services as a key strategic sector. Leading Indian CROs and KOL management companies have established themselves as efficient partners for post-marketing surveillance studies and other real-world evidence programs. Their experience in serving both international and domestic clients across various therapeutic domains has positioned the Asia Pacific region favorably. Growing pharmaceutical market and investments in healthcare research infrastructure in China and other ASEAN countries can drive the market growth.